# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-148119
Filing Date
2019-05-15
Accepted
2019-05-15 17:02:13
Documents
95
Period of Report
2019-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | d726255d10q.htm | 10-Q | 753457
2 | EX-4.5 | d726255dex45.htm | EX-4.5 | 75168
3 | EX-4.6 | d726255dex46.htm | EX-4.6 | 73558
4 | EX-10.14 | d726255dex1014.htm | EX-10.14 | 27095
5 | EX-10.15 | d726255dex1015.htm | EX-10.15 | 33420
6 | EX-10.16 | d726255dex1016.htm | EX-10.16 | 33197
7 | EX-10.17 | d726255dex1017.htm | EX-10.17 | 35879
8 | EX-31.1 | d726255dex311.htm | EX-31.1 | 6400
9 | EX-31.2 | d726255dex312.htm | EX-31.2 | 6413
10 | EX-32.1 | d726255dex321.htm | EX-32.1 | 5507
| Complete submission text file | 0001193125-19-148119.txt |  | 6376137

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL INSTANCE DOCUMENT | xfor-20190331.xml | EX-101.INS | 1146337
12 | XBRL TAXONOMY EXTENSION SCHEMA | xfor-20190331.xsd | EX-101.SCH | 82689
13 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | xfor-20190331_cal.xml | EX-101.CAL | 71831
14 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | xfor-20190331_def.xml | EX-101.DEF | 291069
15 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | xfor-20190331_lab.xml | EX-101.LAB | 609870
16 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | xfor-20190331_pre.xml | EX-101.PRE | 446544

Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38295 | Film No.: 19829423
SIC: 2836 Biological Products, (No Diagnostic Substances)